Literature DB >> 19201828

IL-21: an executor of B cell fate.

Danijela Konforte1, Nathalie Simard, Christopher J Paige.   

Abstract

IL-21 is a type I cytokine that shares the common receptor gamma-chain with IL-2, IL-4, IL-7, IL-9, and IL-15. B cells are one of the lymphoid cell types whose development and function are regulated by IL-21. Depending on the interplay with costimulatory signals and on the developmental stage of a B cell, IL-21 can induce proliferation, differentiation into Ig-producing plasma cells, or apoptosis in both mice and humans. Alone and in combination with Th cell-derived cytokines IL-21 can regulate class switch recombination to IgG, IgA, or IgE isotypes, indicating its important role in shaping the effector function of B cells. This review highlights the role of IL-21 in B cell development, function, and disease and provides some perspectives on the future studies in this area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201828     DOI: 10.4049/jimmunol.0803009

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

2.  A pathogenetic role for IL-21 in primary Sjögren syndrome.

Authors:  Seung-Ki Kwok; Jennifer Lee; Di Yu; Kwi Young Kang; Mi-La Cho; Hae-Rim Kim; Ji Hyeon Ju; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Nat Rev Rheumatol       Date:  2015-01-13       Impact factor: 20.543

3.  During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool.

Authors:  Arvind Dev; Jing Fang; Pradeep Sathyanarayana; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2010-09-01       Impact factor: 22.113

4.  Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood.

Authors:  Veronica Santilli; Alberto Cagigi; Isabella Guzzo; Stefano Rinaldi; Nadia Mora; Federica Zotta; Antonina Piazza; Paolo Rossi; Francesco Emma; Luca Dello Strologo; Paolo Palma
Journal:  Pediatr Nephrol       Date:  2015-12-21       Impact factor: 3.714

5.  Interleukin-21 is associated with disease activity in patients with Graves' disease.

Authors:  Jin Zhang; Hua Zeng; Meng Ren; Haiyan Yan; Mingtong Xu; Zhimei Feng; Weiwen Liang; Chuan Yang; Hua Cheng; Helin Ding; Li Yan
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

6.  IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation.

Authors:  Xiaoran Wu; Yi Tan; Qiao Xing; Shengdian Wang
Journal:  Protein Cell       Date:  2013-11-10       Impact factor: 14.870

7.  Antioxidant treatment regulates the humoral immune response during acute viral infection.

Authors:  Katie E Crump; P Kent Langston; Sujana Rajkarnikar; Jason M Grayson
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.

Authors:  Talibah U Metcalf; Victoria K Baxter; Voraphoj Nilaratanakul; Diane E Griffin
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Inadequate T follicular cell help impairs B cell immunity during HIV infection.

Authors:  Rafael A Cubas; Joseph C Mudd; Anne-Laure Savoye; Matthieu Perreau; Julien van Grevenynghe; Talibah Metcalf; Elizabeth Connick; Amie Meditz; Gordon J Freeman; Guillermo Abesada-Terk; Jeffrey M Jacobson; Ari D Brooks; Shane Crotty; Jacob D Estes; Giuseppe Pantaleo; Michael M Lederman; Elias K Haddad
Journal:  Nat Med       Date:  2013-03-10       Impact factor: 53.440

10.  IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance.

Authors:  Girdhari Lal; Neeraja Kulkarni; Yumi Nakayama; Amit K Singh; Apoorva Sethi; Bryna E Burrell; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Thomas Hehlgans; Jonathan S Bromberg
Journal:  Immunol Lett       Date:  2016-01-06       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.